BioWorld - Wednesday, April 1, 2026

BioWorld Science

May 28, 2002

View Archived Issues

ACH-126443 demonstrates clinical anti-HBV activity

Read More

Solvay requests withdrawal of Luvox NDA

Read More

New data on omalizumab presented at ATS 2002

Read More

Novel metalloproteinase inhibitors designed at DuPont

Read More

CDK4 inhibitors with antitumor activity prepared and tested at Lilly

Read More

Eisai presents novel AMPA/kainate receptor antagonists

Read More

Inhibitors of apo B secretion and their use in lipoprotein disorders

Read More

Applied Research Systems patents JNK inhibitors

Read More

PDE7 inhibitors useful for T-cell-related conditions

Read More

Neurogen claims the preparation and use of CRF1 ligands

Read More

Safety of continuous infusions of GEM-231 and effects on serum extracellular PKA levels

Read More

Novel epothilone examined for pharmacokinetic behavior in phase I trial

Read More

Clinical data for histone deacetylase inhibitor FR-901228 presented in Orlando

Read More

Phase I EMD-72000 results presented at ASCO

Read More

CKD-602 evaluated clinically as a treatment for solid tumors

Read More

MicardisPlus approved in E.U. for hypertension

Read More

Sosei licenses KS Biomedix's TransMID product for recurrent high-grade glioma in Japan

Read More

Intralesional CpG ODN evaluated in patients with basal cell carcinoma and melanoma

Read More

CCI-779 well tolerated and active in renal cell carcinoma

Read More